---
title: "Letter to Shareholders from CEO Dr. Ryan Saadi | TVGN Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286797967.md"
description: "Letter to Shareholders from CEO Dr. Ryan Saadi | TVGN Stock News"
datetime: "2026-05-18T08:15:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286797967.md)
  - [en](https://longbridge.com/en/news/286797967.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286797967.md)
---

# Letter to Shareholders from CEO Dr. Ryan Saadi | TVGN Stock News

Letter to Shareholders from CEO Dr. Ryan Saadi | TVGN Stock News

### Related Stocks

- [TVGNW.US](https://longbridge.com/en/quote/TVGNW.US.md)
- [TVGN.US](https://longbridge.com/en/quote/TVGN.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)

## Related News & Research

- [Liminatus Pharma Announces Proposed Merger with InnocsAI to Expand Oncology Cell Therapy Pipeline | LIMN Stock News](https://longbridge.com/en/news/287218720.md)
- [Korro Bio To Advance KRRO-111 As Potential Treatment For AATD](https://longbridge.com/en/news/287089978.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Immix Biopharma Announces 95% Complete Response Rate In Interim Update From Relapsed/Refractory AL Amyloidosis Clinical Trial NEXICART-2](https://longbridge.com/en/news/287200923.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)